The Institute of Biomedical Science (IBMS) has welcomed the publication of Pathology Transformation Review 2026 and its recognition that pathology is central to the future of the NHS. This evidence-based report, authored by Lord Carter, highlights the need to recognise pathology as a core clinical service requiring sustained investment, proactive workforce planning and better use of its professional expertise.
Features
Cracks in the foundation: glass slides and the future of digital pathology
The evolution of digital pathology has revolutionised the study of tissue. But could the traditional glass slide be holding back the potential of digital workflows and artificial intelligence in histopathology? Rachel Finn looks at what is required of microscope slides and cover glass to realise the full benefits of digital technology.
Sepsis: plasma viscosity as a diagnostic marker
David Norcliffe, David Manuel and Bernie Benson examine the role of plasma viscosity as a diagnostic marker in sepsis and also plasma–serum viscosity ratio as a predictor of disseminated intravascular coagulation.
Products
New LIAISON tuberculosis assay improves efficiency and productivity
Diasorin and QIAGEN have announced the launch of the new CE-marked LIAISON QuantiFERON-TB Gold Plus II, a next-generation assay that redefines speed and throughput as an aid in the diagnosis of tuberculosis infection on LIAISON analyser systems.
Menarini introduces Coyote FlashDetect PCR device range
Menarini has added Coyote FlashDetect PCR to its range of diagnostic solutions. These scalable rapid PCR devices will enable users to gain high quality results within 35 minutes.
QIAGEN unveils QIAsymphony Connect at AMP 2025
QIAGEN has launched QIAsymphony Connect, the next generation of its widely adopted automated nucleic acid purification platform, at the 2025 AMP (Association for Molecular Pathology) annual meeting.
ProtonDx's Dragonfly evaluated for identifying hidden malaria cases
A new study has shown that Dragonfly, a low-cost, rapid, molecular testing platform is successfully able to detect asymptomatic malaria infections.
Latest Issues
pfm medical UK Limited is the UK subsidiary of pfm medical gmbh.
Located in the Cheshire countryside, we are committed to supplying high quality products to the NHS, Private Hospitals, Research and Development Centre’s, Laboratories and all other care services.
We have been established since 2007 and have a strong team of clinical...
UK NEQAS webinar: Introduction to Immunocytochemistry
Online
14-15 July, 2026
UK NEQAS webinar: Introduction to Direct Immunofluorescence
Online
16 July, 2026
IHC Antibody Recognition & Expression Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
4 August, 2026
IHC Technical Issues Master Class
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
5 August, 2026
ECP 2026 - 38th European Congress of Pathology
Stockholmsmässan, Stockholm, Sweden
12-16 September, 2026